HR 71
- Session Year: 2023-2024
- House: Assembly
- Latest Version Date: 2024-02-15
Current Status:
Failed
(2024-03-14: Read. Adopted. (Ayes 70. Noes 0. Page 4374.).)
Introduced
In Committee
First Chamber
In Committee
Second Chamber
Enacted
WHEREAS, Multiple system atrophy (MSA) is a rare and progressive neurodegenerative disorder characterized by a combination of symptoms that affect both the autonomic nervous system and movement; and
WHEREAS, According to the National Institute of Neurological Disorders and Stroke, MSA may affect between 15,000 and 50,000 Americans, including men and women of all races; and
WHEREAS, Symptoms, including problems with heart rate, progressive loss of motor function, and difficulties with balance, coordination, gait, bladder and bowel control, speech, swallowing, and breathing, advance rapidly over the course of 5 to 10 years once symptoms initially appear; and
WHEREAS, While there are medications that treat MSA symptoms, researchers continue to search for medications with fewer side effects as well as methods to better manage the disease until a cure is found; and
WHEREAS, A multidisciplinary approach to MSA care includes physical, psychological, and financial support for patients, caregivers, support groups, and MSA research foundations; and
WHEREAS, The worldwide MSA community has designated March as Multiple System Atrophy Awareness Month to increase awareness of the devastating effects of MSA; now, therefore, be it
Resolved by the Assembly of the State of California, That the Assembly declares the month of March 2024 as Multiple System Atrophy Awareness Month; and be it further
Resolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.
|
Date
|
Status
|
|---|---|
| Mar 14, 2024 | Coauthors revised. |
| Mar 14, 2024 | Read. Adopted. (Ayes 70. Noes 0. Page 4374.). |
| Mar 11, 2024 | From committee: Be adopted. To Consent Calendar. (Ayes 10. Noes 0.) (March 11). |
| Feb 20, 2024 | Referred to Com. on RLS. |
| Feb 15, 2024 | Introduced. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Mar 14, 2024 | HR 71 Mike Fong Consent Calendar Second Day Regular Session | Assembly Floor |
Passed |
|
| Mar 11, 2024 | Be adopted. To Consent Calendar. | Assembly Standing Committee on Rules |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
Date of Hearing: March 11, 2024
ASSEMBLY COMMITTEE ON RULES
Blanca Pacheco, Chair
ABPCA Bill Id:HR 71 (
Author:Mike Fong) – As Introduced Ver:February 15, 2024
SUBJECT: Multiple System Atrophy Awareness Month.
SUMMARY: Declares the month of March 2024 as Multiple System Atrophy Awareness Month. Specifically, this resolution makes the following legislative findings:
- Multiple system atrophy (MSA) is a rare and progressive neurodegenerative disorder characterized by a combination of symptoms that affect both the autonomic nervous system and movement.
- According to the National Institute of Neurological Disorders and Stroke, MSA may affect between 15,000 and 50,000 Americans, including men and women of all races.
- Symptoms, including problems with heart rate, progressive loss of motor function, and difficulties with balance, coordination, gait, bladder and bowel control, speech, swallowing, and breathing, advance rapidly over the course of 5 to 10 years once symptoms initially appear.
- While there are medications that treat MSA symptoms, researchers continue to search for medications with fewer side effects as well as methods to better manage the disease until a cure is found.
- A multidisciplinary approach to MSA care includes physical, psychological, and financial support for patients, caregivers, support groups, and MSA research foundations.
- The worldwide MSA community has designated March as Multiple System Atrophy Awareness Month to increase awareness of the devastating effects of MSA.
FISCAL EFFECT: None
REGISTERED SUPPORT / OPPOSITION:
Support
None on file
Opposition
None on file
Analysis Prepared by: Michael Erke / RLS. / (916) 319-2800
Bill Author
Bill Co-Author(s):